A summary of relationships between alternative splicing and breast cancer

被引:9
作者
Zhang Xiping [1 ]
Wei Qingshan [2 ]
Zhao Shuai [1 ]
Yang Hongjian [1 ]
Ding Xiaowen [1 ]
机构
[1] Zhejiang Canc Hosp, Dept Breast Surg, Hangzhou 310022, Zhejiang, Peoples R China
[2] Lib Xian Jiaotong Univ, Cataloging Dept, Xian 710049, Shaanxi, Peoples R China
关键词
alternative splicing; breast cancer; spliceosome; variants; ESTROGEN-RECEPTOR-ALPHA; DIFFERENTIAL EXPRESSION; CELL-PROLIFERATION; POTENTIAL ROLE; ER-ALPHA; CD44; GROWTH; ER-ALPHA-36; HNRNP; ISOFORMS;
D O I
10.18632/oncotarget.17727
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Alternative splicing (AS) is the process of combinatorial rearrangement of parts of exons, and/or parts of introns into mature RNA to result in a multitude of transcripts. AS is a biological process through which organisms produce as many protein variants as possible by a limited genetic resource. It plays an important role in growth and development of the organisms. Over the past few years, alternative splicing has been discovered to be critical for genesis and development of malignant tumors, including breast cancer. If the relationships between AS and breast cancer can be discussed more deeply, it will be helpful for better diagnosis, judging prognosis and intervening with breast cancer. In this paper, the relationships between AS and breast cancer are elaborated from different angles, in hope that this summary is beneficial for readers to understand the roles of AS and breast cancer.
引用
收藏
页码:51986 / 51993
页数:8
相关论文
共 68 条
[1]   Role of Rac1/WAVE2 Signaling in Mediating the Inhibitory Effects of γ-Tocotrienol on Mammary Cancer Cell Migration and Invasion [J].
Algayadh, Ibrahim Gayadh ;
Dronamraju, Venkateshwararao ;
Sylvester, Paul William .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2016, 39 (12) :1974-1982
[2]   WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing [J].
Amin, Elianna M. ;
Oltean, Sebastian ;
Hua, Jing ;
Gammons, Melissa V. R. ;
Hamdollah-Zadeh, Maryam ;
Welsh, Gavin I. ;
Cheung, Man-Kim ;
Ni, Lan ;
Kase, Satoru ;
Renne, Emma S. ;
Symonds, Kirsty E. ;
Nowak, Dawid G. ;
Royer-Pokora, Brigitte ;
Saleem, Moin A. ;
Hagiwara, Masatoshi ;
Schumacher, Valerie A. ;
Harper, Steven J. ;
Hinton, David R. ;
Bates, David O. ;
Ladomery, Michael R. .
CANCER CELL, 2011, 20 (06) :768-780
[3]   Rationale for targeting fibroblast growth factor receptor signaling in breast cancer [J].
Andre, Fabrice ;
Cortes, Javier .
BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (01) :1-8
[4]   Advances and challenges in targeting FGFR signalling in cancer [J].
Babina, Irina S. ;
Turner, Nicholas C. .
NATURE REVIEWS CANCER, 2017, 17 (05) :318-332
[5]   The potential role of estrogen receptor β2 in breast cancer [J].
Baek, Jong-Min ;
Chae, Byung-Joo ;
Song, Byung-Joo ;
Jung, Sang-Seol .
INTERNATIONAL JOURNAL OF SURGERY, 2015, 14 :17-22
[6]   Fox-2 mediates epithelial cell-specific fibroblast growth factor receptor 2 exon choice [J].
Baraniak, AP ;
Chen, JR ;
Garcia-Blanco, MA .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (04) :1209-1222
[7]   CD44 as a potential diagnostic tumor marker [J].
Basakran, Nawwaf S. .
SAUDI MEDICAL JOURNAL, 2015, 36 (03) :273-279
[8]  
Bièche I, 1999, CANCER RES, V59, P2546
[9]   hnRNP A1-mediated translational regulation of the G quadruplex-containing RON receptor tyrosine kinase mRNA linked to tumor progression [J].
Cammas, Anne ;
Lacroix-Triki, Magali ;
Pierredon, Sandra ;
Le Bras, Morgane ;
Iacovoni, Jason S. ;
Teulade-Fichou, Marie-Paule ;
Favre, Gilles ;
Roche, Henri ;
Filleron, Thomas ;
Millevoi, Stefania ;
Vagner, Stephan .
ONCOTARGET, 2016, 7 (13) :16793-16805
[10]   Listening to silence and understanding nonsense: Exonic mutations that affect splicing [J].
Cartegni, L ;
Chew, SL ;
Krainer, AR .
NATURE REVIEWS GENETICS, 2002, 3 (04) :285-298